Glycolipid metabolic disorders, linked to cardiovascular diseases and cancer, are a major global health challenge. Current single-disease treatments remain ​unsatisfied in reducing long-term risks. In 2024, Professor Jiao Guo along with global experts launched the "Global Initiative for Glycolipid Metabolic Health" to enhance prevention through scientific research, public education, and integrated management systems.

Scientists sampled worn face masks from travelers and health care workers. Team detected a diverse but mostly harmless mix of bacterial species. Most airborne bacteria came from human skin, not illness. Surprisingly, microbial communities from hospitals and airplanes were highly similar.